AICDA and irritable bowel syndrome: The proposed mechanisms of action for the IBD-AID include modulation of the gut microbiota, reduction in dietary pro-inflammatory triggers, and incorporation of anti-inflammatory components such as omega-3 fatty acids and polyphenols [122].